Rhythms & Cardiac Emergencies
									
... • Obtain baseline vitals before and/or during ECG monitoring • Identify rhythm and determine corresponding SOP to follow – Helpful to have at least one more person verify strip • Obtain patient history & OPQRST of current complaint ...
                        	... • Obtain baseline vitals before and/or during ECG monitoring • Identify rhythm and determine corresponding SOP to follow – Helpful to have at least one more person verify strip • Obtain patient history & OPQRST of current complaint ...
									Management of Ventricular Tachycardia
									
... in several studies. A recent meta-analysis, including studies of patients with both ischaemic and non-ischaemic cardiomyopathy, demonstrated a substantial mortality benefit [15] See (Table 2) for studies included. There was a 50% relative risk reduction in arrhythmic deaths and a 27% risk reduct ...
                        	... in several studies. A recent meta-analysis, including studies of patients with both ischaemic and non-ischaemic cardiomyopathy, demonstrated a substantial mortality benefit [15] See (Table 2) for studies included. There was a 50% relative risk reduction in arrhythmic deaths and a 27% risk reduct ...
									CARDIAC MASSES
									
... – Endocrine tumors (pituitary adenomas, adrenocortical disease or testicular tumors)33% ...
                        	... – Endocrine tumors (pituitary adenomas, adrenocortical disease or testicular tumors)33% ...
									The influence of a low ejection fraction on long-term
									
... Objective: Poor left-ventricular ejection fraction (EF) is a recognized operative and long-term risk factor in coronary artery bypass surgery. Over the past decade, off-pump coronary artery bypass surgery has emerged as a new strategy to address myocardial revascularization in poor left-ventricular ...
                        	... Objective: Poor left-ventricular ejection fraction (EF) is a recognized operative and long-term risk factor in coronary artery bypass surgery. Over the past decade, off-pump coronary artery bypass surgery has emerged as a new strategy to address myocardial revascularization in poor left-ventricular ...
									Medtronic Receives FDA Approval and CE Mark for Arctic Front
									
... 3 Medtronic, Inc. Arctic Front Cardiac CryoAblation Catheter clinical reports, in support of FDA premarket approval. 4 Packer D. et al, Journal of the American College of Cardiology. 2013 Mar 13 doi: 10.1016/j.jacc.2012.11.064. 5 Chugh S, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of a ...
                        	... 3 Medtronic, Inc. Arctic Front Cardiac CryoAblation Catheter clinical reports, in support of FDA premarket approval. 4 Packer D. et al, Journal of the American College of Cardiology. 2013 Mar 13 doi: 10.1016/j.jacc.2012.11.064. 5 Chugh S, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of a ...
									Valve Sparing Surgery for Papillary Fibroelastoma of the Aortic Valve
									
... the papillary surface.5 The matrix consists of proteoglycans, elastic fibers, and rarely spindle cells. The fibrinous matrix is the hallmark of this tumor. Clinically, most CPF are found incidentally at the time of cardiac investigation for unrelated problem, or at autopsy. 3 The most common clinica ...
                        	... the papillary surface.5 The matrix consists of proteoglycans, elastic fibers, and rarely spindle cells. The fibrinous matrix is the hallmark of this tumor. Clinically, most CPF are found incidentally at the time of cardiac investigation for unrelated problem, or at autopsy. 3 The most common clinica ...
									aortic_stenosis
									
... the balloon is expanded to open the narrowing) of the outflow tract during heart catheterization may result in improvement of clinical signs in some dogs ...
                        	... the balloon is expanded to open the narrowing) of the outflow tract during heart catheterization may result in improvement of clinical signs in some dogs ...
									Congenitally corrected transposition of great arteries with ischemic
									
... Discussion. Transposition of the great arteries comprises 2.6 - 7.8% of all cases of congenital heart diseases, and if uncorrected, is commonly fatal in the first year of life.7 The clinical course is complicated by associated intracardiac defects such as ventricular septal defect, subvalvar and val ...
                        	... Discussion. Transposition of the great arteries comprises 2.6 - 7.8% of all cases of congenital heart diseases, and if uncorrected, is commonly fatal in the first year of life.7 The clinical course is complicated by associated intracardiac defects such as ventricular septal defect, subvalvar and val ...
									The Cardiac Cycle, Cardiac Output, Cardiac Regulation
									
... – Left ventricle ejects less blood (e.g. Rt V ejects 70 ml and Lt V ejects 50 ml) – Rt. Ventricle is ejecting 20 ml more blood than Lt. ventricle during each cardiac cycle – extra “20 ml” most go somewhere // it accumulates in the lung interstitial space // pulmonary edema – shortness of breath or s ...
                        	... – Left ventricle ejects less blood (e.g. Rt V ejects 70 ml and Lt V ejects 50 ml) – Rt. Ventricle is ejecting 20 ml more blood than Lt. ventricle during each cardiac cycle – extra “20 ml” most go somewhere // it accumulates in the lung interstitial space // pulmonary edema – shortness of breath or s ...
									Jan De Pooter - Ghent University Library
									
... regarding QRSD and CRT response. We measured QRSD with different methods and assessed their value to predict CRT response. Methods: ECGs pre- and post-CRT from 52 CRT patients (66±12 yrs, 65% male) were analysed retrospectively. Custom-made software was developed to measure global QRSD (QRSDglobal) ...
                        	... regarding QRSD and CRT response. We measured QRSD with different methods and assessed their value to predict CRT response. Methods: ECGs pre- and post-CRT from 52 CRT patients (66±12 yrs, 65% male) were analysed retrospectively. Custom-made software was developed to measure global QRSD (QRSDglobal) ...
									Sp02 = Pulse Oximetry Oxygen Saturation Level PAP = Mean
									
... Must be a documented positive effect within ½ hour of initiation. Improved PAP, and/or increased C.O., and/or improved oxygenation and/or oxygen Saturation shall be considered positive effect for these indications. a. Cardiac surgery complicated by Pulmonary Arterial Hypertension (PAH) and RV dysfun ...
                        	... Must be a documented positive effect within ½ hour of initiation. Improved PAP, and/or increased C.O., and/or improved oxygenation and/or oxygen Saturation shall be considered positive effect for these indications. a. Cardiac surgery complicated by Pulmonary Arterial Hypertension (PAH) and RV dysfun ...
									Changes in Left Ventricular Filling in Patients with Persistent Atrial
									
... rhythm except the restoration of atrial contraction; however the observation period was relatively short. On the other hand, in a study conducted by Caputo and colleagues the E/Em ratio was the only significant predictor of recurrent AF in following year after ECV (9). Ejima et al. tried to evaluate ...
                        	... rhythm except the restoration of atrial contraction; however the observation period was relatively short. On the other hand, in a study conducted by Caputo and colleagues the E/Em ratio was the only significant predictor of recurrent AF in following year after ECV (9). Ejima et al. tried to evaluate ...
									ESPEN Guidelines on Enteral Nutrition: Cardiology and Pulmonology
									
... of patients. However, at the recent American Heart Association meeting in Dallas, USA (November 2005), Anker reported that in the COMET study of 3000 CHF patients in NYHA classes II–IV who were all treated with one of two beta-blockers for a period of 5 years, weight gain was independently associate ...
                        	... of patients. However, at the recent American Heart Association meeting in Dallas, USA (November 2005), Anker reported that in the COMET study of 3000 CHF patients in NYHA classes II–IV who were all treated with one of two beta-blockers for a period of 5 years, weight gain was independently associate ...
									Management by Hypothermia of Junctional Ectopic Tachycardia
									
... controlling HR. In this series of patients hypothermia associated with the use of a pacemaker was an effective, safe option. Hemodynamic changes occurred within a few hours, and no side effects directly attributable to hypothermia were seen. Although the small number of patients we studied does not ...
                        	... controlling HR. In this series of patients hypothermia associated with the use of a pacemaker was an effective, safe option. Hemodynamic changes occurred within a few hours, and no side effects directly attributable to hypothermia were seen. Although the small number of patients we studied does not ...
									AFIB COCHRANE
									
... cardioversion as the first intervention, and trials of new onset atrial fibrillation after cardiac surgery. There were no language restrictions. DATA COLLECTION AND ANALYSIS: For dichotomous data, odds ratios were calculated; and for continuous data, the weighted mean difference was calculated. MAIN ...
                        	... cardioversion as the first intervention, and trials of new onset atrial fibrillation after cardiac surgery. There were no language restrictions. DATA COLLECTION AND ANALYSIS: For dichotomous data, odds ratios were calculated; and for continuous data, the weighted mean difference was calculated. MAIN ...
									An Overview of Ventricular Assist Devices
									
... 1. Does the patient have all of the necessary VAD equipment for transport 2. Determine the closest VAD implanting medical center ...
                        	... 1. Does the patient have all of the necessary VAD equipment for transport 2. Determine the closest VAD implanting medical center ...
									stroke prevention in atrial fibrillation objective
									
... No significant difference in mortality is anticipated in the overall treated population. Effects on mortality may be more pronounced in patients at higher risk of stroke. Dabigatran: The RELY study compared dabigatran, an oral direct thrombin inhibitor, 150 mg twice daily and 110 mg twice daily, to ...
                        	... No significant difference in mortality is anticipated in the overall treated population. Effects on mortality may be more pronounced in patients at higher risk of stroke. Dabigatran: The RELY study compared dabigatran, an oral direct thrombin inhibitor, 150 mg twice daily and 110 mg twice daily, to ...
									Automated External Defibrillators (AED)
									
... A victim's best chance for survival is when there is revival within 4 minutes. Having more people who can respond to medical emergencies and trained to use AEDs will greatly increase survival rates for people in sudden cardiac arrest. ACEP supports increased public access to AEDs that is coordinated ...
                        	... A victim's best chance for survival is when there is revival within 4 minutes. Having more people who can respond to medical emergencies and trained to use AEDs will greatly increase survival rates for people in sudden cardiac arrest. ACEP supports increased public access to AEDs that is coordinated ...
									look - Weebly
									
... ventricles per contraction). To maintain an adequate cardiac output (i.e. volume of blood pumped out of the heart in one minute) to meet Martha's metabolic needs, she must either (A) increase the strength of contraction (i.e. increased contractility), and / or (B) increase the heart rate (i.e. the n ...
                        	... ventricles per contraction). To maintain an adequate cardiac output (i.e. volume of blood pumped out of the heart in one minute) to meet Martha's metabolic needs, she must either (A) increase the strength of contraction (i.e. increased contractility), and / or (B) increase the heart rate (i.e. the n ...
									Irbesartan in Patients with Heart Failure and Preserved Ejection
									
... Patients were started on 75 mg of irbesartan or placebo once daily. The dose was doubled to 150 mg after 1 to 2 weeks and was doubled again to 300 mg after an additional 1 to 2 weeks, according to a forced-titration protocol as tolerated. In addition to the titration visits, patients were seen 8 wee ...
                        	... Patients were started on 75 mg of irbesartan or placebo once daily. The dose was doubled to 150 mg after 1 to 2 weeks and was doubled again to 300 mg after an additional 1 to 2 weeks, according to a forced-titration protocol as tolerated. In addition to the titration visits, patients were seen 8 wee ...
									Right atrial dyssynchrony and atrial fibrillation after
									
... Introduction: Prevalence of post-coronary bypass grafting surgery (post-CABG) atrial fibrillation (AF) is high, and it’s complications are serious. Prediction of this problem and prophylactic or presumably curative managements may be helpful not only in post-CABG AF, but also in other conditions tha ...
                        	... Introduction: Prevalence of post-coronary bypass grafting surgery (post-CABG) atrial fibrillation (AF) is high, and it’s complications are serious. Prediction of this problem and prophylactic or presumably curative managements may be helpful not only in post-CABG AF, but also in other conditions tha ...
									Dilated Cardiomyopathy - Children`s Cardiomyopathy Foundation
									
... In some cases, more invasive cardiac tests may be necessary. A cardiac catheterization is the most useful and accurate tool for diagnosing cardiovascular problems. It can be used to check for blockage in the arteries, measure heart and lung pressures, evaluate the heart’s pumping ability and perform ...
                        	... In some cases, more invasive cardiac tests may be necessary. A cardiac catheterization is the most useful and accurate tool for diagnosing cardiovascular problems. It can be used to check for blockage in the arteries, measure heart and lung pressures, evaluate the heart’s pumping ability and perform ...
									Cardiovascular Pharmacology
									
... atria in the mechanism of the tachycardia. Many SVTs are due to extra, abnormal electrical connections between the atria and the ventricles. Individuals with SVT are often born with these extra pathways. The existence of such extra pathways (often called “bypass tracts”) allow the formation of “reen ...
                        	... atria in the mechanism of the tachycardia. Many SVTs are due to extra, abnormal electrical connections between the atria and the ventricles. Individuals with SVT are often born with these extra pathways. The existence of such extra pathways (often called “bypass tracts”) allow the formation of “reen ...
Cardiac contractility modulation
                        Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.